FIELD: gastroenterology.
SUBSTANCE: method involves simultaneously introducing Panavir and Ganavir. Panavir is introduced intravenously in daily dose 5 ml of 0.004% solution, course: 3 injections with interval 48 h and then, 3 days latter, 2 injections with interval 48 h. Galavin is introduced intramuscularly in daily dose 100 mg, course: 5 injections with interval 24 h and then 10 injections with interval 48 h.
EFFECT: achieved elimination of virus, normalization of clinical and biochemical characteristics in absence of side effects.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING MODERATELY ACTIVE AND REPLICATIVE CHRONIC VIRAL HEPATITIS TYPE C OF 1-GENOTYPE | 2009 |
|
RU2398582C1 |
METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
METHOD OF ARRESTING HEPATITE "C" CHRONISATION | 2007 |
|
RU2331436C1 |
METHOD FOR TREATING PATIENTS FOR VIRAL HEPATITIS C | 2002 |
|
RU2212248C1 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
METHOD OF TREATMENT OF CHILDREN WITH VIRAL HEPATITIS B | 1998 |
|
RU2154478C2 |
METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
METHOD FOR TREATING THE CHRONIC VIRAL HEPATITIS C PATIENTS HAVING HEPATIC HEMOSIDEROSIS | 1999 |
|
RU2180599C2 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
Authors
Dates
2007-09-27—Published
2005-12-28—Filed